Aktieanalys

IRLAB: Positive top-line from IRL757 phase I study - Redeye

{newsItem.title}

Redeye Publicerad: 31 Jan 11:28

IRLAB Therapeutics

Redeye comments on the news that IRLAB has presented positive top-line data from the phase I study in healthy older adults.

Länk till analysen i sin helhet: https://www.redeye.se/research/1071576/irlab-positive-top-line-from-irl757-phase-i-study?utm_source=finwire&utm_medium=RSS

Nyheter om IRLAB Therapeutics

Läses av andra just nu

Om aktien IRLAB Therapeutics

Senaste nytt